目次

Table of Contents

1. Pegfilgrastim Biosimilars Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Application
6.3. Segmentation By Distribution Channel

7. Pegfilgrastim Biosimilars Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Application
7.2.1. Chemotherapy Induced Neutropenia
7.2.2. Transplantation
7.2.3. Others
7.3. Market Segmentation By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Mail Order Pharmacies

8. Pegfilgrastim Biosimilars Market Trends And Strategies
8.1. Revised FDA Regulations To Facilitate Biosimilar Drug Development
8.2. Robust Research & Development
8.3. Large Number Of Strategic Partnerships
8.4. Growing Mergers And Acquisitions
8.5. Demand For Biosimilars In The Treatment Of Neutropenia

9. Impact Of COVID-19 On Pegfilgrastim Biosimilars Market
9.1. Impact On Global Pegfilgrastim Biosimilars Market
9.2. Clinical Trial Delays
9.3. Impact On Patients
9.4. Impact On Major Players
9.5. Future Outlook

10. Global Pegfilgrastim Biosimilars Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2020
10.2.2. Restraints On The Market 2015 - 2020
10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
10.3.1. Drivers Of The Market 2020 - 2025
10.3.2. Restraints On The Market 2020 - 2025

11. Global Pegfilgrastim Biosimilars Market Segmentation
11.1. Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.1.1. Chemotherapy Induced Neutropenia
11.1.2. Transplantation
11.1.3. Others
11.2. Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.2.3. Mail-Order Pharmacies

12. Pegfilgrastim Biosimilars Market, Regional And Country Analysis
12.1. Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Pegfilgrastim Biosimilars Market
13.1. Asia-Pacific Pegfilgrastim Biosimilars Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Asia-Pacific Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.4. Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Pegfilgrastim Biosimilars Market: Country Analysis
13.6. China Pegfilgrastim Biosimilars Market
13.7. China Pegfilgrastim Biosimilars Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Background Information
13.7.4. Government Initiatives
13.7.5. Regulations
13.7.6. Regulatory Bodies
13.7.7. Major Associations
13.7.8. Taxes Levied
13.7.9. Corporate Tax Structure
13.7.10. Investments
13.7.11. Major Companies
13.8. China Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.9. China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.10. India Pegfilgrastim Biosimilars Market
13.11. India Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.12. India Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.13. India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.14. Japan Pegfilgrastim Biosimilars Market
13.15. Japan Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.16. Japan Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.17. Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.18. Australia Pegfilgrastim Biosimilars Market
13.19. Australia Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.20. Australia Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.21. Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.22. Indonesia Pegfilgrastim Biosimilars Market
13.23. Indonesia Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.24. Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.25. South Korea Pegfilgrastim Biosimilars Market
13.26. South Korea Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.27. South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Pegfilgrastim Biosimilars Market
14.1. Western Europe Pegfilgrastim Biosimilars Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.3. Western Europe Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.4. Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Pegfilgrastim Biosimilars Market: Country Analysis
14.6. UK Pegfilgrastim Biosimilars Market
14.7. UK Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.8. UK Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.9. UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.10. Germany Pegfilgrastim Biosimilars Market
14.11. Germany Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.12. Germany Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.13. Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.14. France Pegfilgrastim Biosimilars Market
14.15. France Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.16. France Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.17. France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Pegfilgrastim Biosimilars Market
15.1. Eastern Europe Pegfilgrastim Biosimilars Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Taxes levied
15.1.9. Corporate Tax Structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
15.3. Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.4. Eastern Europe Pegfilgrastim Biosimilars Market: Country Analysis
15.5. Russia Pegfilgrastim Biosimilars Market
15.6. Russia Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
15.7. Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Pegfilgrastim Biosimilars Market
16.1. North America Pegfilgrastim Biosimilars Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulations
16.1.6. Regulatory Bodies
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate Tax Structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
16.4. North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Pegfilgrastim Biosimilars Market: Country Analysis
16.6. USA Pegfilgrastim Biosimilars Market
16.7. USA Pegfilgrastim Biosimilars Market Overview
16.7.1. Country Information
16.7.2. Market Information
16.7.3. Background Information
16.7.4. Government Initiatives
16.7.5. Regulations
16.7.6. Regulatory Bodies
16.7.7. Major Associations
16.7.8. Taxes Levied
16.7.9. Corporate Tax Structure
16.7.10. Investments
16.7.11. Major Companies
16.8. USA Pegfilgrastim Biosimilars Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.9. USA Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
16.10. USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Pegfilgrastim Biosimilars Market
17.1. South America Pegfilgrastim Biosimilars Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
17.3. South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.4. South America Pegfilgrastim Biosimilars Market: Country Analysis
17.5. Brazil Pegfilgrastim Biosimilars Market
17.6. Brazil Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
17.7. Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Pegfilgrastim Biosimilars Market
18.1. Middle East Pegfilgrastim Biosimilars Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Major Associations
18.1.8. Taxes levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.3. Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Pegfilgrastim Biosimilars Market
19.1. Africa Pegfilgrastim Biosimilars Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Pegfilgrastim Biosimilars Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.3. Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Pegfilgrastim Biosimilars Market Competitive Landscape
20.1. Company Profiles
20.2. Coherus Biosciences Inc.
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Sandoz (Novartis)
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Biocon
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Mylan
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Intas Biopharmaceuticals Ltd
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview
20.7. Mundipharma GmbH
20.7.1. Company Overview
20.7.2. Products And Services
20.7.3. Business Strategy
20.7.4. Financial Overview
20.8. Dr. Reddy’s Laboratories
20.8.1. Company Overview
20.8.2. Products And Services
20.8.3. Business Strategy
20.8.4. Financial Overview
20.9. Pfizer Inc.
20.9.1. Company Overview
20.9.2. Products And Services
20.9.3. Business Strategy
20.9.4. Financial Overview
20.10. Emcure Pharmaceuticals (Gennova Biopharmaceuticals Ltd.)
20.10.1. Company Overview
20.10.2. Products And Services
20.10.3. Financial Overview
20.11. USV Private Limited
20.11.1. Company Overview
20.11.2. Products And Services
20.11.3. Business Strategy
20.11.4. Financial Overview

21. Pegfilgrastim Biosimilars Market Pipeline Analysis

22. Key Mergers And Acquisitions In The Pegfilgrastim Biosimilars Market
22.1. AbCellera Acquired TetraGenetics
22.2. Ligand Pharmaceuticals Acquired Pfenex
22.3. True North Acquired Stake In Biocon Biologics
22.4. Coherus BioSciences Inc Acquired Innovent Biologics Co. Ltd.
22.5. Biocon Acquires Pfizer's R&D Facility To Boost Biosimilars Development
22.6. AbbVie Acquired Allergan
22.7. Kashiv Pharma Acquired Adello Biologics
22.8. Mundipharma International Limited Acquired Cinfa Biotech
22.9. Biocon Merged With Sandoz
22.10. Fresenius Kabi Acquired The Biosimilars Business Of Merck KGaA

23. Pegfilgrastim Biosimilars Market Future Outlook and Potential Analysis
23.1. Global Pegfilgrastim Biosimilars Market In 2025 - Countries Offering Most New Opportunities
23.2. Global Pegfilgrastim Biosimilars Market In 2025 - Segments Offering Most New Opportunities
23.3. Global Pegfilgrastim Biosimilars Market In 2025 - Growth Strategies
23.3.1. Market Trend Based Strategies
23.3.2. Competitor Strategies

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer

List of Tables
Table 1: Global Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 2: Global Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 3: Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 4: Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 5: Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 6: Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 7: Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
Table 8: Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 9: Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
Table 10: Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 11: Asia Pacific Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 12: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
Table 13: Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
Table 14: Asia Pacific Per Capita Net Disposable Income, 2015-2020, $
Table 15: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
Table 16: Asia Pacific GDP Per Capita, 2015-2020, $
Table 17: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 18: Asia-Pacific Biologics Market Size, 2015-2025, $ Billion
Table 19: Asia-Pacific Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 20: Asia-Pacific Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 21: Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 22: Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 23: China Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 24: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
Table 25: China Per Capita Net Disposable Income, 2015-2020, $
Table 26: China, Population By Age Group, 2015-2025, Thousands
Table 27: China GDP Per Capita, 2015-2020, $
Table 28: China, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 29: China Biologics Market Size, 2015-2025, $ Billion
Table 30: China Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 31: China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 32: China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 33: India Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 34: India Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 35: India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 36: India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 37: Japan Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 38: Japan Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 39: Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 40: Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 41: Australia Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 42: Australia Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 43: Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 44: Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 45: Indonesia Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 46: Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 47: Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 48: South Korea Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 49: South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 50: South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 51: Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
Table 52: Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
Table 53: Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
Table 54: Western Europe Per Capita Net Disposable Income, 2015-2020, $
Table 55: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
Table 56: Western Europe GDP Per Capita, 2015-2020, $
Table 57: Western Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 58: Western Europe Biologics Market Size, 2015-2025, $ Billion
Table 59: Western Europe Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 60: Western Europe Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 61: Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 62: Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 63: UK Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 64: UK Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 65: UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 66: UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 67: Germany Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 68: Germany Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 69: Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 70: Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 71: France Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 72: France Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 73: France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 74: France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 75: Eastern Europe Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 76: Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
Table 77: Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
Table 78: Eastern Europe Per Capita Net Disposable Income, 2015-2020, $
Table 79: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
Table 80: Eastern Europe GDP Per Capita, 2015-2020, $
Table 81: Eastern Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 82: Eastern Europe Biologics Market Size, 2015-2025, $ Billion
Table 83: Eastern Europe Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 84: Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 85: Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 86: Russia Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 87: Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 88: Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 89: North America Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 90: North America Public Healthcare Expenditure, 2015-2020, $ Billion
Table 91: North America Private Healthcare Expenditure, 2015-2020, $ Billion
Table 92: North America Per Capita Net Disposable Income, 2015-2020, $
Table 93: North America, Population By Age Group, By Country, 2015-2025, Thousands
Table 94: North America GDP Per Capita, 2015-2020, $
Table 95: North America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 96: North America Biologics Market Size, 2015-2025, $ Billion
Table 97: North America Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 98: North America Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 99: North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 100: North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 101: USA Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 102: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
Table 103: USA Per Capita Net Disposable Income, 2015-2020, $
Table 104: USA, Population By Age Group, 2015-2025, Thousands
Table 105: USA GDP Per Capita, 2015-2020, $
Table 106: USA Home, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 107: USA Biologics Market Size, 2015-2025, $ Billion
Table 108: USA Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Table 109: USA Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 110: USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 111: USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 112: South America Estimated Average Expenditure, Pegfilgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 113: South America Public Healthcare Expenditure, 2015-2020, $ Billion
Table 114: South America Private Healthcare Expenditure, 2015-2020, $ Billion
Table 115: South America Per Capita Net Disposable Income, 2015-2020, $
Table 116: South America, Population By Age Group, By Country, 2015-2025, Thousands
Table 117: South America GDP Per Capita, 2015-2020, $
Table 118: South America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 119: South America Biologics Market Size, 2015-2025, $ Billion
Table 120: South America Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 121: South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 122: South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 123: Brazil Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 124: Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 125: Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 126: Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
Table 127: Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
Table 128: Middle East Per Capita Net Disposable Income, 2015-2020, $
Table 129: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
Table 130: Middle East GDP Per Capita, 2015-2020, $
Table 131: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 132: Middle East Biologics Market Size, 2015-2025, $ Billion
Table 133: Middle East Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 134: Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 135: Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 136: Africa Public Healthcare Expenditure, 2015-2020, $ Billion
Table 137: Africa Private Healthcare Expenditure, 2015-2020, $ Billion
Table 138: Africa Per Capita Net Disposable Income, 2015-2020, $
Table 139: Africa, Population By Age Group, By Country, 2015-2025, Thousands
Table 140: Africa GDP Per Capita, 2015-2020, $
Table 141: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 142: Africa Biologics Market Size, 2015-2025, $ Billion
Table 143: Africa Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Table 144: Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Table 145: Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
Table 146: Global Pegfilgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019 & 2020, Percentage (%)
Table 147: Sandoz (Novartis) - Financial Performance, 2016 - 2020, $ Billion
Table 148: Biocon - Financial Performance, 2016 - 2020, $ Billion
Table 149: Mylan - Financial Performance, 2016 - 2020, $ Billion
Table 150: Intas Biopharmaceuticals Ltd - Financial Performance, 2015 - 2019, $ Billion
Table 151: Dr. Reddy’s Laboratories - Financial Performance, 2016 - 2020, $ Billion
Table 152: Pfizer Inc. - Financial Overview, 2016 - 2020, $ Billion
Table 153: Emcure Pharmaceuticals - Financial Performance, 2016 - 2020, $ Billion
Table 154: Global Pegfilgrastim Biosimilars Market, Pipeline Analysis
Table 155: Global Pegfilgrastim Biosimilars Market Size Gain ($ Million), 2020 - 2025, By Country
Table 156: Global Pegfilgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Application, 2020 - 2025
Table 157: Global Pegfilgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 - 2025
Table 158: Pegfilgrastim Biosimilars - Market Data Sources

List of Figures
Figure 1: Global Pegfilgrastim Biosimilars Market Segmentation By Application
Figure 2: Global Pegfilgrastim Biosimilars Market Segmentation By Distribution Channel
Figure 3: Global Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 4: Global Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 5: Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 6: Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 7: Global Pegfilgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 8: Global Pegfilgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 9: Asia-Pacific Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 10: Asia-Pacific Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 11: Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 12: China Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 13: China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 14: India Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 15: India Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 16: India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 17: Japan Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 18: Japan Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 19: Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 20: Australia Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 21: Australia Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 22: Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 23: Indonesia Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 24: Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 25: South Korea Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 26: South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 27: Western Europe Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 28: Western Europe Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 29: Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 30: UK Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 31: UK Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 32: UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 33: Germany Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 34: Germany Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 35: Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 36: France Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 37: France Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 38: France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 39: Eastern Europe Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 40: Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 41: Russia Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 42: Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 43: North America Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 44: North America Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 45: North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 46: USA Pegfilgrastim Biosimilars Market, Historic, 2015 - 2020, $ Million
Figure 47: USA Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 48: USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 49: South America Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 50: South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 51: Brazil Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 52: Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 53: Middle East Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 54: Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 55: Africa Pegfilgrastim Biosimilars Market, Forecast, 2020 - 2025, 2030F, $ Million
Figure 56: Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
Figure 57: Global Pegfilgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
Figure 58: Global Pegfilgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
Figure 59 Sandoz (Novartis) - Financial Performance, 2016 - 2020, $ Billion
Figure 60: Biocon - Financial Performance, 2016 - 2020, $ Billion
Figure 61: Mylan - Financial Performance, 2016 - 2020, $ Billion
Figure 62: Intas Biopharmaceuticals Ltd - Financial Performance, 2015 - 2019, $ Billion
Figure 63: Dr. Reddy’s Laboratories - Financial Performance, 2016 - 2020, $ Billion
Figure 64: Pfizer Inc. - Financial Overview, 2016 - 2020, $ Billion
Figure 65: Emcure Pharmaceuticals - Financial Performance, 2016 - 2020, $ Billion